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LC8 functions as a dimer crucial for a variety of molecular motors and
non-motor complexes. Emerging models, founded on structural studies,
suggest that the LC8 dimer promotes the stability and refolding of dimeric
target proteins in molecular complexes, and its interactions with selective
target proteins, including dynein subunits, is regulated by LC8
phosphorylation, which is proposed to prevent LC8 dimerization. To test these
hypotheses in vivo, we determine the impacts of two new LC8 mutations on
the assembly and stability of defined LC8-containing complexes in
Chlamydomonas flagella. The three types of dyneins and the radial spoke are
disparately affected by dimeric LC8 with a C-terminal extension. The defects
include the absence of specific subunits, complex instability, and reduced
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incorporation into the axonemal super complex. Surprisingly, a
phosphomimetic LC8 mutation, which is largely monomeric in vitro, is still
dimeric in vivo and does not significantly change flagellar generation and
motility. The differential defects in these flagellar complexes support the
structural model and indicate that modulation of target proteins by LC8leads
to the proper assembly of complexes and ultimately higher level complexes.
Furthermore, the ability of flagellar complexes to incorporate the
phosphomimetic LC8 protein and the modest defects observed in the
phosphomimetic LC8 mutant suggest that LC8 phosphorylation is not an
effective mechanism for regulating molecular complexes.

LC8 is an important component of vital complexes such as
cytoplasmic dynein, myosin V, neuronal nitric-oxide synthase (1), and
the nuclear pore complex (2). In Chlamydomonas flagella, LC8 is
found in three types of dynein motors (the outer dynein arm (ODA),3
the inner dynein arm (IDA) called the I1 dynein, and the cytoplasmic
dynein motor CD1b for intraflagellar transport (IFT)) and in the radial
spoke (RS) (3–7). The LC8-null mutant, fla14, has short, paralyzed
flagella in which these complexes are absent or reduced (6) (Table 1).
Drastic pleiotropic phenotypes also are noted in Drosophila LC8
mutants (8). In particular, the amorph mutant is embryonic lethal
because of apoptotic death, consistent with the discovery that LC8
helps to sequester the pro-death apoptotic factor Bim (9).
Despite its significance, the function and regulation of LC8 are
only partially understood. LC8 functions as a dimer with two identical
binding sites for the target proteins (10, 11). One model postulates
that the dimer tethers dynein motors to various cargoes (12).
However, in some systems, the role of LC8 is unrelated to dynein
motors (1, 13, 14). Another emerging model, founded upon structural
analyses, contends that the bivalent structure of the LC8 dimer
increases the stability (15) and promotes the refolding of the scaffold
proteins in the complex (16).
Additional data indicate that LC8 is regulated by phosphorylation
(17–19). The C-terminal Ser88 residue is phosphorylated in tumor
cells, and the phosphorylation may promote cell survival by release
and subsequent degradation of Bim (17). Consistent with this idea, a
phosphomimetic LC8S88E mutant protein is predominantly monomeric
in vitro and cannot bind to Bim or the target peptide from IC74 of
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cytoplasmic dynein (18, 19). However, LC8S88E does bind to peptides
of Swallow, a target protein in the Drosophila oocyte (18). It was
postulated that Swallow peptides have a stronger affinity for LC8 and
bind to the small dimeric pool of LC8S88E, reversing the monomeric
shift, and that LC8 phosphorylation is a selective regulatory
mechanism. These observations raise a critical question about LC8
phosphorylation as a regulatory mechanism. How can phosphorylated
LC8 promote cell survival while failing to bind vital target proteins,
such as intermediate chains in cytoplasmic dynein? Testing these
models for functional and regulatory mechanisms ultimately requires in
vivo analyses.
In this study, we characterize the Chlamydomonas mutant pf5
(20). The PF5 gene product was implicated in integrating the assembly
and function of axonemes because in addition to an RS deficiency and
the lack of two minor RS proteins, RSP13 and RSP15, pf5 axonemes
also lack a small protein and an ~110-kDa polypeptide of the inner
dynein arms. The RS is part of a system that controls the activation of
axonemal dynein motors. We discovered that the intriguing phenotype
of pf5 is actually caused by a mutation in the LC8 gene FLA14. This
new mutant, expressing LC8 with a C-terminal extension (LC8CT), and
an additional LC8 phosphomimetic mutant (LC8S90E) were used for
analyses of the assembly and stability of the defined LC8-containing
dyneins and the RS complexes in the Chlamydomonas flagellum (Table
1). Comparison of the phenotypes from these two new mutants and
the LC8 null mutant (6) strongly support the predicted structural role
of LC8 on target proteins to promote the stability and assembly of
individual complexes at various levels. Furthermore, our results
suggests that this function and molecular complexes are not
significantly altered by LC8 phosphorylation.

Experimental Procedures
Strains and Culture Conditions
The following Chlamydomonas strains were used in this study:
CC124 (WT mt—), CC1331 (pf5 mt—), and CC3937 (fla14-1 mt+). All
strains were obtained from the Chlamydomonas Center (St. Paul, MN)
and were cultured as described (21, 22) unless indicated otherwise.
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The fla14-1 strain was used for transformations with LC8
constructs (described below; see Table 1). Transformants used for this
study include fla14-LC8, fla14-LC8CT, fla14-LC8S90A, and fla14LC8S90E (transformed with WT LC8, LC8CT, LC8S90A, and LC8S90E
constructs, respectively).

Molecular Biology, LC8 Genomic Constructs
The paromomycin resistance cassette was amplified from the
pSI103 vector (21) and blunt-end cloned into the pBluescript vector at
the SmaI site to generate the pPMM plasmid. Subsequently, LC8
genomic fragments, containing 0.55 and 1 kb of 5’- and 3’-flanking
sequences (23) and the LC8 coding region, were PCR-amplified
fromWTand CC1331 genomic DNA. The PCR products were cloned into
the XhoI site in pPMM to generate pPMM-LC8 and pPMM-LC8CT
plasmids.
For the LC8S90E phosphomimetic construct, PCR mutagenesis
was performed to mutate the Ser90 codon (TCG) to a glutamate codon
(GAA) using a primer containing the mutated sequence and a nearby
BssHII restriction sequence. The PCR product was used to replace the
equivalent fragment in the pPMM-LC8 plasmid to generate the pPMMLC8S90E plasmid. For the LC8S90A construct, PCR-based site-directed
mutagenesis was carried out using the QuickChange mutagenesis kit
(Stratagene, La Jolla, CA).

Expression of His-tagged Recombinant Proteins
LC8 coding sequences were PCR-amplified and cloned into the
NdeI and EcoRI sites of pET28(a) vector. The constructs were
transformed into BL21(DE3) for expression as described (21). All
constructs were confirmed by restriction digest and sequencing.

Genetics
Transformation rescue and genetic crosses were performed as
described (21, 22). The experiments in which fla14-1 was transformed
with WT and mutant LC8 constructs allow for a direct comparison of
the impacts of the LC8 mutations in an identical genetic background.
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Biochemistry
Axoneme Isolation—Axoneme isolation, high salt extractions at
5 mg/ml and velocity sedimentation were carried out as described
(21).
Analytical Gel Filtration Chromatography—Purified, recombinant
LC8 proteins were dialyzed in 50 m phosphate/citrate buffer, pH 3 or
pH 7, for 24 h. 100-l aliquots of 50 M protein were fractionated on a
Superose 12 HR 10/30 column with the dialysis buffer at a flow rate of
0.1 ml/min powered by an AKTA FPLC system.
Chemical Cross-linking—Isolated axonemes were treated with
1,5-difluoro-2,4-dinitrobenzene (Pierce) at a series of concentrations
as described (10). After treatment, the axonemes were fixed for SDSPAGE and analyzed by Western blots.
Antibodies—Antibodies were used in Western blots at 1:5000
dilutions to detect the following axonemal structures: for LC8 and the
ODA, LC8 and IC78 (Dr. S. M. King, University of Connecticut Health
Center) and IC69 (Dr. D. R. Mitchell, SUNY State Medical School); for
I1 dynein, IC140, IC138, and IC97 (Dr. W. S. Sale, Emory University);
for single-headed IDAs, p28 (Dr. G. Piperno, Mount Sinai Medical
School); for the retrograde IFT motor CD1b, DLIC (Dr. M. E. Porter,
University of Minnesota); and for the RS, RSP1 and RSP3 (Drs. D. R.
Diener; J. L. Rosenbaum, Yale University) and RSP8, RSP11, and
RSP16 (24).

Light Microscopy
Bright field light microscopy for motility assessment, imaging,
and statistics was carried out as described (21). For flagellar length
measurement, cells were fixed in 50% Lugol solution (Sigma). Images
were magnified х2 optically and further enlarged х6 digitally. Flagella
were traced on the monitor with a cotton thread, and the length was
measured by a ruler. The measurement was converted to actual length
by comparison with an image of a micrometer taken in parallel.
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Results
pf5 Mutant Displays Multiple Flagellar Defects Because of a
Mutation in the LC8 Gene—The pf5 strain, CC1331, exhibits paralyzed
or twitching flagella, typical for RS mutants with the occasional, slow
swimming cell. We also found that these cells were defective in
flagellar generation as well. Compared with the 10–12-m WT flagella
(Fig. 1A, upper panel), CC1331 flagella were about one-half length
(Fig. 1A, lower panel; Table 1). Some cells have unequal length
flagella (Fig. 1A, arrowhead) or flagella with swollen tips (Fig. 1A,
arrow in insets), a phenotype typical of IFT mutants defective in the
subunits of CD1b, the retrograde IFT motor, such as LC8 (6, 25).
To characterize the protein deficiencies in pf5, we performed
Western blots of axonemes, probing for the subunits of the flagellar
dyneins and the RS, structures that are crucial for flagellar motility and
generation (Fig. 1B). As reported previously (20), compared with
different loads of the WT control, the RS in pf5 axonemes, represented
by RSP16 and RSP3, was reduced to ~50%, and the lower band for
RSP3, indicative of the dephosphorylated form (26), was more
prominent. The lack of RSP13 and RSP15 (20) was not further
confirmed because antibodies to these RS subunits are not available.
In contrast, the light intermediate chain (DLIC) of the retrograde IFT
motor CD1b (25, 27), IC140 in I1 (28), p28 in single-headed IDAs
(29), and IC78, LC6, and LC9 of the ODA (30) were not obviously
affected. Interestingly, IC97 (also called IC110) in I1 (31) was not
detectable, indicating IC97 is the missing 110-kDa IDA component in
pf5 (20) and is not essential for the assembly of I1.
To determine whether the multiple defects observed in CC1331
were caused by a single mutation, the CC1331 strain was backcrossed
to WT. The motility and axonemes of tetrads derived from 10 zygotes
were analyzed. Segregation of the CC1331 motility phenotype was 2:2
with only parental di-types observed (10:0:0). As shown in the
representative Western blots of axonemes (Fig. 2A), dephosphorylated
RSP3 (dot), absence of IC97, and short twitching flagella (T) always
co-segregated, whereas phosphorylated RSP3 and IC97 were only
present in axonemes from 100%WTswimmers (S). The strict cosegregation of these biochemical markers and the motility anomaly
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suggested that the phenotypes are caused by a single mutation or
tightly linked mutations.
To determine the genetic defect in pf5, transformation rescue
experiments were carried out. CC1331 was co-transformed with BAC
DNA that mapped near the pf5 locus on linkage group III and a
plasmid that confers paromomycin (PMM) resistance for selection. Only
BAC DNA containing the LC8-encoding FLA14 gene rescued the pf5
mutant phenotype (data not shown). To determine whether pf5 is
defective in the LC8 gene, FLA14 genomic DNA from CC1331 was
amplified by PCR and sequenced. Two independent experiments
showed that the TAA stop codon is replaced with the leucine-encoding
TTA codon (asterisk, Fig. 2B) leading to an extended C terminus with
an additional 23 amino acids, including 4 charged residues. The
mutation is expected to result in a larger LC8 protein with a more
basic pI than WT LC8. This result is consistent with the report that a
small protein, presumably WT LC8, in the two-dimensional map of pf5
axonemes was absent (20). Secondary structure analysis with the PHD
program predicts that the addition also changes the conformation of
the last -strand (5, Fig. 2B). As predicted, Western analysis showed
that LC8 with the extended C terminus (LC8CT) was incorporated into
CC1331 axonemes and is slightly larger than LC8 from WT axonemes
(Fig. 2C).
To confirm that the CC1331 phenotypes were because of the
read-through mutation in the LC8 gene, CC1331 cells were
transformed with a single plasmid containing the WTLC8 gene (FLA14)
and a paromomycin expression cassette for selection. The prediction is
that the WT FLA14 gene will rescue the flagellar length and motility
defects in CC1331. Among 200 transformants, 86 clones were
randomly selected for further analyses. Based on the motility, they
were categorized into three groups: CC1331-like, WT-like, and mixed
populations. Axonemes from each group were analyzed by Western
blots (Fig. 2D). The CC1331-like clones (H7, H8, and G1) were
immotile, had difficulty generating flagella (see low amounts of
tubulin), and their axonemes still had high levels of dephosphorylated
RSP3 (Fig. 2D, dot). Interestingly, axonemes from the transformants
with swimmers contained both forms of LC8 (LC8CT andWTLC8).
Those with only ~30% swimmers (A1, B12, and C10 strains) had more
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LC8CT than WT LC8, whereas the strains with 100% swimmers
contained largely WT LC8 (B11 strain) or a similar level of WT LC8 and
LC8CT (B1 strain). Thus, LC8CT can compete withWTLC8 for assembly
into the axoneme, and 50% WT LC8 is sufficient to restore WT-like
motility. In the rescued strains, IC97 was restored, and RSP3 was
largely phosphorylated. The varied ratio of WT LC8/LC8CT is likely
because of different expression levels from the randomly inserted
plasmid. CC1331-like transformants are likely because of the failed
integration of theWTLC8 gene from the transforming plasmid.
Based on backcross, sequencing, and transformation rescue, we
conclude that the read-through mutation of the LC8 gene results in the
combined deficiencies in flagellar length (Fig. 1A) and multiple
axonemal complexes, including IC97 in I1 (Fig. 1B). Therefore,
CC1331 (designated as pf5) and fla14 are defective in the same locus,
and pf5 is renamed as fla14-3 after the two null mutants (6).
Curiously, the FLA14 gene from strain CC1028, which is listed as a pf5
strain (Chlamydomonas Center), is normal and can rescue CC1331
phenotypes (data not shown). Thus, the paralysis of CC1028 is
because of a mutation in a different locus.
In Vitro Analysis of Recombinant LC8 Variants—Structural
analyses indicate the two C termini, including Ser88, of the rat LC8
dimer are positioned in close proximity to the dimeric interface but not
at the target binding sites (Fig. 3A). A phosphomimetic mutation in
Ser88 (Fig. 3A, S88E; yellow residues with side chains) near the C
terminus prevents dimerization in vitro because of charge repulsion,
suggesting that phosphorylation is a mechanism for regulating LC8 by
controlling dimer formation (18).
We postulate that the residues and charges in the additional Cterminal tail of Chlamydomonas LC8CT perturb dimerization leading to
the severe phenotypes of the LC8CT strain (fla14-3). To test this,
recombinant LC8, LC8CT, and LC8S90E (equivalent to S88E) were
analyzed by gel filtration chromatography. As expected, at pH 7, WT
LC8 was dimeric, and LC8S90E was largely monomeric (Fig. 3B).
However, contrary to our hypothesis, recombinant LC8CT migrates as
a slightly larger particle than WT LC8, indicating that LC8CT actually
forms stable dimers. As expected, all LC8 constructs were monomeric
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at pH 3 because of protonation (16). Therefore, the deficiencies in
LC8CT flagella are not because of a defect in its dimerization.
Effect of Phosphomimetic LC8S90E on Flagellar Complexes in
Vivo—Because Drosophila phosphomimetic LC8S88E cannot bind IC74
of cytoplasmic dynein in vitro, we predict that the equivalent
monomeric LC8S90E will result in severe deficiencies in the ODA, I1,
and retrograde IFT. To test this, fla14-1 was transformed with a
plasmid expressing LC8S90E, WT LC8, LC8CT, or LC8S90A, a variant
that cannot be phosphorylated (19).
More than 50 transformants for each construct were screened
microscopically. As expected, theWTLC8 gene completely rescued the
fla14-1 phenotype (fla14-LC8), whereas the LC8CT transformants
(fla14-LC8CT) resembled fla14-3 (CC1331), with short, paralyzed
flagella. Interestingly, fla14-LC8CT flagella were slightly longer than
those of fla14-1, and both gradually shorten as time progressed
(compare CT and null in Fig. 4A), even in the presence of WT levels of
the retrograde motor (see DLIC in Fig. 1B). To our surprise, LC8S90E
transformants (fla14-S90E) appeared indistinguishable from WT LC8
strain in flagellar length (compare LC8 and S90E, Fig. 4D) and overall
motility. A detailed analysis of three LC8S90E strains by high speed
video microscopy (21) showed that their flagellar waveform was
similar to WT LC8 strains, but the beat frequency was slightly slower
(Table 1), a common trait of mutants with mild defects in the ODA
(32).
To determine whether LC8S90E proteins were incorporated into
the axoneme as monomers, isolated axonemes were treated with
increasing concentrations of the short length cross-linker 1,5-difluoro2,4-dinitrobenzene, which has been shown to cross-link axonemal LC8
dimers (10). Western blots showed that, in axonemes, LC8S90E was
cross-linked into dimers as does WT LC8 (Fig. 4B), indicating that
although LC8S90E is monomeric in vitro, it is incorporated into
axonemes as a dimer in vivo.
To determine whether LC8S90E transformants exhibit any
axonemal defects, axonemes with LC8S90E and WT LC8 were
compared by Western blots. Interestingly, IC97 failed to assemble in
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LC8S90E axonemes (Fig. 4C), a result similar to that observed in
LC8CT axonemes (Fig. 1B). In addition, LC6 and LC9 from the ODA
were reduced, a result that differed from LC8CT axonemes. The slight
defect in ODA assembly is consistent with the slightly reduced beat
frequency observed in these transformants (Table 1). However, in
some preparations, these deficiencies were not as severe, suggesting
variability in the assembly of these complexes in the LC8S90E strains.
LC8S90A strains were indistinguishable from WT controls (data not
shown).
Because of the varied severities in the LC8S90E phenotype, we
tested if the deficiency could be enhanced by culturing cells in adverse
conditions, on agar plates in a dim-lighted room at 32°C for 14 days
followed by resuspension in water at 32°C. All strains were assessed
as percentage swimmers at three time points after resuspension.
Under these conditions, the fla14-1 and fla14-LC8CT strains were
entirely immotile, and most cells lacked flagella (Fig. 4D, fla14-1 and
LC8CT). Although fast swimmers were noted in the fla14-LC8 and
fla14-S90A strains after 30 min, only ~10–50% cells swam in 3.5 h
(Fig. 4D, WT and S90A), indicating the culture condition was not
favorable for flagellar generation. Importantly, the LC8S90E swimmers
did not appear until 3.5 h (Fig. 4D, S90E), and the movement was
sluggish. Together, these results indicate that LC8S90E affects the
ODA more severely than other flagellar complexes. The deficiency
becomes more severe and extends to other flagellar complexes when
cells are grown in challenging conditions. As additional controls,
LC8S90E cells grown in 32 or 24°C growth chambers with bright light
and controlled humidity appear normal (data not shown), indicating
the enhanced phenotype of LC8S90E is not merely because of
temperature sensitivity.
Dissociation of Axonemal Dyneins and RS Complexes in LC8
Mutants—To test if the mutant LC8 molecules affect the stability of
flagellar complexes, axonemal dyneins were extracted by 0.6  NaCl
followed by velocity sedimentation in 5–20% sucrose gradients and
Western blot analyses (Fig. 5A). As anticipated for WT, the ODA and I1
sedimented as intact ~20 S particles (represented by IC78 and IC140,
respectively), and LC8 primarily co-sedimented with the abundant
ODA. In the fla14-LC8CT strain, the ODA remained at ~20 S. In
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contrast, IC140 sedimented as a smaller particle, at a position similar
to p28 (Fig. 5A, arrow) in single-headed dyneins, and IC138 was found
in multiple peaks, indicating the I1 complex is less stable and
dissociates upon extraction. Interestingly, in the LC8S90E gradient,
even though IC97 was absent, I1 did not dissociate, whereas the ODA
did (Fig. 5A, IC78 and IC69). In this case, IC78 sedimented closer to
the top of the gradient, although IC69 sedimented at a position similar
to IC140 in the LC8CT gradient. Thus, I1 is more sensitive to LC8CT,
although the ODA is more sensitive to LC8S90E. Because CD1b
dissociates readily under these conditions (27), the stability of this
complex was not assessed.
To test the effect of the LC8 mutations on the stability of the RS
complexes, axonemes were extracted with 0.5  KI and then
fractionated similarly. As shown by RSP16 Western blot, the RSs
sedimented as intact 20 S particles (Fig. 5B). In contrast, in LC8CT
extracts, all RSPs tested, including RSP16 and four other RSPs that are
located at different subdomains of the RS complex (24), sedimented
near the top of the gradient, indicating a drastic disintegration of the
RS. Therefore, LC8CT interferes with the assembly of individual RS
complexes, phosphorylation of RSP3, and the incorporation of the RS
into axonemes (Fig. 1B and Fig. 5B).

Discussion
The major challenges in understanding LC8 function are the
severe pleiotropic phenotypes of the previously described LC8 mutants
and the lack of in vivo context in the simplified in vitro systems. These
constraints are overcome by the two new LC8 mutants and the
Chlamydomonas experimental system with defined LC8-containing
complexes. The key results are that phosphomimetic LC8S90E,
although monomeric in vitro, is a dimer in vivo and only causes minor
defects. In contrast, dimeric LC8CT results in disparate assembly
deficiencies and the dissociation of complexes that are otherwise
rather stable. These results support the proposed structural role of LC8
in forming a core scaffold (15, 16) and shed new light on the
regulation and ultimate function of LC8.
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LC8 Promotes the Formation of the Retrograde IFT Motor for the
Generation of Full-length Flagella—Because the transient short flagella
of fla14-1 lack retrograde IFT and the responsible motor CD1b, it was
postulated that retrograde IFT recycled the IFT machinery for flagellar
generation and maintenance, and thus fla14 generated short flagella
that resorb prematurely because of depleted IFT rafts (6). Yet defects
in multiple axonemal complexes in fla14-1 could result in short flagella
(29). The IFT deficiency model was confirmed by fla14-3 (LC8CT
strain) that also displayed a similar length phenotype but milder
axonemal defects that are insufficient to affect flagellar length.
Interestingly, the amount of DLIC appears normal in LC8CT flagella
(Fig. 1B) indicating that the retrograde IFT motor can enter flagella,
but its function is still impaired. Importantly, the defects in the IFT
motor and axonemal complexes appear independent.
LC8 Directly Promotes the Proper Assembly of Individual
Complexes at Multiple Levels—One theory proposes that numerous
LC8 target proteins are the cargoes of dynein motors and that the
bivalent LC8 dimers adhere the motors and the cargoes together. This
idea is consistent with the deficiencies of the LC8 null flagella in which
the retrograde IFT motor, CD1b, is absent and its putative axonemal
cargoes are reduced or absent. However, defective motorcargo
coupling cannot explain the defects in LC8CT-containing flagella in
which retrograde IFT is dysfunctional, although the ODA appears
largely normal; the RS is unstable (Fig. 5B) and poorly incorporated
into axonemes, and I1 is only missing a single subunit (20) (Fig. 1),
and it dissociates upon extraction (Fig. 5A). Such disparate structural
deficiencies in the four flagellar complexes are indicative of individual
assembly defects and strongly suggest that LC8, normal or mutated, is
in a critical position in each flagellar complex to directly affect the
assembly unique to each complex.
These deficiencies can be partially explained by the model that
the LC8 dimer stabilizes or refolds dimeric scaffold molecules in
molecular complexes (15, 16). It is conceivable that the LC8 dimer
associates with putative scaffold proteins, such as WD-repeat ICs in
dyneins (30) (Fig. 6, left) and unknown proteins in the RS. This
binding can enhance the stability of dimeric scaffold proteins and
transform the flanking disordered regions into a conformation that
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favors the association with additional molecules, such as IC97 in I1,
the LCs in the ODA (Fig. 4), RSP13/15 in the RS (20), IFT particle
proteins in the case of CD1b, or docking proteins responsible for
anchoring axonemal complexes. Thus, through modulation of target
proteins, LC8 promotes the assembly of various complexes and higher
level complexes. When LC8 is mutated, such as LC8CT, the additional
sequence (Fig. 6, right, red triangles) at the dimeric interface may act
as a wedge that alters the dimeric conformation or creates steric
hindrance, consequently reducing the stability of the complex and
interfering with further interactions.
As instrumental and important as LC8 is, it is critical to attribute
its contribution objectively to understand the grander scheme of
molecular assembly. Contrary to the prediction (33), LC8 is not
necessary for initiating assembly and may not be involved in the
initiation process at all. Studies of fla14-1 showed that without LC8,
flagellar LC8 complexes actually assemble, although the process is
defective at different steps for each complex. For example, the
subunits of CD1b are dispersed in the cell body of a DLIC mutant (25,
27, 34), indicating that this subunit is essential for assembly of the
retrograde IFT motor. In contrast, in WT and the LC8 null mutant
(fla14-1), the other subunits of CD1b are concentrated around the
peribasal body region. Thus, in the absence of LC8, the retrograde IFT
motor is assembled into a defective complex that cannot enter flagella.
In the case of the RS, the precursor RS complex enters flagella (26)
but cannot be incorporated into axonemes, resulting in the absence of
RS structures in fla14-1 axonemes. I1 is assembled in fla14-1
axonemes, although it is less abundant (6). Thus, the modulation of
target proteins by LC8 is to correctly promote further assembly rather
than to initiate the assembly of complexes.
The unique subunits in I1 also caution the strict interpretation
that LC8 target proteins only function as molecular scaffolds (16). The
actual target proteins of LC8 in I1 have not been determined.
However, neither IC138, a candidate scaffold molecule with WD
repeats, nor IC97, which is most sensitive to the LC8 mutations, is
required for I1 assembly (31, 35). Instead, both are implicated in
phosphoregulation of I1 (31, 35, 36). These unique subunits explain
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the less severe defects of I1 in fla14-1 and demonstrate the varied
roles of LC8 target proteins.
Differential Accommodation of Mutated LC8—The scaffold model
portrays LC8 actively refolding target proteins (16). This study shows
the individual ability of each flagellar complex to accommodate the
modified LC8 molecules. For example, the ODA accommodates LC8CT
better than LC8S90E, whereas the other complexes accommodate
LC8S90E better than LC8CT.
Two possibilities can explain these differences. Despite a
common LC8-binding motif (37, 38), the actual LC8-binding sequences
are longer and rather diverged (11) and may have different affinity for
mutated LC8 proteins. Furthermore, the molecular context of each LC8
complex, which cannot be tested in vitro, may influence how severe a
particular complex will be affected by each LC8 mutation. For example,
it was postulated that five tightly packed LC8 dimers promote the
folding of the dimeric scaffold proteins in the yeast nuclear pore
complex (2). Similarly, two LC8-binding sites are immediately adjacent
to each other in the WD repeat subunit of CD1b (34) that is
particularly sensitive to LC8CT. It is conceivable that multiple tightly
packed LC8CT dimers with additional tails will amplify the impact on
the target proteins and complexes.
In contrast, the target proteins and neighboring subunits of
each complex, which are also involved in assembly of the scaffold (15,
30, 39), may contribute to the ability of each complex in
accommodating a particular LC8 mutation, particularly the
phosphomimetic LC8 that is inherently monomeric in vitro (Fig. 3),
thus reducing or eliminating the impact of modified LC8.
Limited Effects of LC8 Phosphoregulation—It has been proposed
that LC8 phosphorylation is a selective regulatory mechanism (18).
The subtle phenotype in the LC8S90E phosphomimetic mutants
suggests that the phospho-regulation is more restricted than
anticipated. One idea is that LC8 phosphorylation induces a monomeric
shift that preferentially interferes with the binding of lower affinitive
target proteins, such as the intermediate chain target peptides from
Drosophila dynein (18). Consistently, the ODA and I1 in
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Chlamydomonas flagellar are abnormal (this study). However, the
important differences are that the flagellar dyneins incorporate
LC8S90E as dimers (Fig. 4B), and the defects are insufficient to cause
obvious functional deficiencies in Chlamydomonas flagella in standard
laboratory growth conditions (Fig. 4A). Although the phosphomimetic
mutation is not identical to phosphorylation, these modest effects from
LC8S90E raise doubts on the effectiveness of LC8 phosphorylation in
regulating flagellar functions and molecular complexes in general. In
fact, to date, we have not been able to identify phosphorylated LC8 in
Chlamydomonas flagella (data not shown). The strains with LC8S90A
that cannot be phosphorylated appear normal as well. This tolerance of
phosphorylated LC8 by most complexes could be advantageous such
that phosphorylated LC8 could primarily affect a small number of
target proteins, like apoptotic factor, to promote cell survival (17, 19)
without causing deleterious side effects such as the disruption of
dynein motors.
The enhanced phenotypes of the phosphomimetic mutants in
adverse conditions suggest that the conserved Ser90 is important but
not for phosphorylation. The deficiency of S90E flagella became more
severe under dimmer light and warmer growth condition that even
challenges WT (Fig. 4D) but is not unusual in natural habitats. Yet it is
under this condition that the difference between WT and the
phosphomimetic mutant becomes evident. Perhaps the
phosphomimetic LC8 is less effective in promoting assembly. The
inefficiency is masked under ideal laboratory conditions but becomes
apparent in challenging situations in which myriads of cellular
reactions, such as protein synthesis, are critically reduced. As shown in
a structural study, the hydroxyl group of Ser88 at the interface may
contribute a hydrogen bond (18) that favors the dimerization to
effectively promote the proper assembly of molecular complexes under
diverse conditions.
As small as LC8 is, it has been assigned an accolade of titles. By
taking advantage of Chlamydomonas mutants and the well
characterized LC8-containing flagellar complexes, this study has
provided the critical in vivo evidence and the molecular context to
substantiate the structural model for LC8 function, further revealing
the ultimate function for LC8 in fostering the proper assembly of
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flagellar complexes and the limit of postulated phosphoregulation.
These conclusions are likely applicable to diverse complexes as well as
higher level complexes that contain LC8 in other systems (40, 41).
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FIGURE 1. pf5 strain, CC1331, has multiple flagellar defects. A, most
CC1331 cells (CC1331; bottom panel) are stationary with paralyzed or
twitching flagella that are one-half the length of wild-type flagella (WT; upper
panel). On occasion, flagella of unequal lengths (arrowhead) and flagella with
swollen tips (arrow in insets) are observed. B, Western blots of isolated
axonemes reveal defects in I1 dynein and the RS in CC1331. Different loads
of axonemes were included to better reveal the reduction level. The I1-dynein
subunit, IC97, is undetectable, whereas the WD repeat subunit, IC140,
appears normal. Two representative radial spoke proteins, RSP3 and RSP16,
are reduced to less than 50% of the WT level, and the dephosphorylated form
of RSP3 is more prominent in CC1331 (lower band in CC1331 RSP3 lane).
IC78, LC6, and LC9 in the ODA, DLIC in CD1b, and p28 (a component of
several single-headed IDAs) appear normal.
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FIGURE 2. CC1331 phenotype is because of a read-through mutation in the
LC8 gene. A, motility and Western blots of isolated axonemes from
representative progeny derived from a cross between CC1331 and WT reveal
only parental di-type tetrads, twitching flagella (T) characteristic of the
CC1331 phenotype and wild-type swimming cells (S). The phenotypes,
including twitching short flagella (T), dephosphorylated RSP3 (dot), and the
absence of IC97, strictly co-segregate. B, comparison of the C-terminal
sequences of LC8 in CC1331 and WT. The stop codon in the LC8 gene is
mutated into a leucine codon (asterisk), resulting in the addition of 23 amino
acids at the C terminus. This C-terminal extension may alter the original 5th strand into a helix (h). C, Western blot shows that the LC8 with a C-terminal
extension (LC8CT) is present in CC1331 axoneme and slightly larger than WT
LC8. The middle lane contains both WT and CC1331 axonemes. D,
representative Western blots show that the WT LC8 gene rescues the motility
and axonemal deficiencies of CC1331. In the axonemes of the transformants,
WT LC8 co-assembles with the larger endogenous LC8CT. The ratio of
WT:LC8CT correlates with the percentage of swimmers and the amount of
IC97 and phosphorylated RSP3. Interestingly, 50% assembly of WT LC8
rescues the flagellar phenotypes (B1). Like the CC1331 parental strain, the
CC1331-like strains (H8, G1, and H7) yield less axonemes (see tubulin
protein stain), but dephosphorylated RSP3 (dot), typical of CC1331
axonemes, is still observed.
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FIGURE 3. Two C-terminal mutations affect LC8 dimerization differently. A,
tertiary structure modeling illustrates the location of Ser88 (yellow residues
with side chains) and the C terminus near the dimeric interface. The diagram
is based on the NMR study of the rat LC8 dimer (blue and green) and Bim
peptide (pink) (12) and was generated by the web-based program, Protein
Data Bank Workshop 1.50. B, gel filtration shows that at pH 7 LC8CT migrates
as a larger particle than dimericWTLC8 and the monomeric phosphomimetic
LC8S90E (upper panel). In contrast, at pH 3, all LC8 forms migrate primarily
as monomers (bottom panel).
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FIGURE 4. S90E mutation in Chlamydomonas LC8 results in subtle
phenotypes. For these experiments, fla14-1 was transformed with constructs
to express LC8, LC8CT, LC8S90E, and LC8S90A. A, flagellar lengths of the
transformants expressing LC8 variants. Each data point was obtained from
measuring 100 flagellated cells from each transformant at different time
points after the beginning of the light cycle. As expected, the WT LC8
transformant has full-length flagella (LC8) and the LC8CT transformant has
short flagella that are about one-half the length of wild type and slightly
longer than that of fla14-1. The transformants expressing the LC8S90E
protein are full-length (S90E). CT, C terminus. B, Western blot of axonemes
treated with increasing concentrations of 1,5-difluoro-2,4-dinitrobenzene
shows that LC8S90E is cross-linked into a dimer as effectively as WT LC8
(arrowhead). C, Western blots of isolated axonemes demonstrate IC97 from
I1 is absent, and LC6 and LC9 from ODA are reduced in axonemes from
LC8S90E transformants (lanes #17, #8, and #2). RS assembly appears
normal (RSP3 and RSP16). IC140 and p28 are unaffected and thus serve as
loading controls. D, differences between LC8S90E transformants and the
control, LC8S90A, and WT become obvious when cultured in a dimly lighted
32 °C room. The histogram shows the percentage of swimmers after
resuspension of cells from agar plate. Note under this condition, 10–50% of
the cells in the control groups can swim after 0.5–3 h, compared with ~100%
in the standard laboratory condition. However, only ~10% LC8S90E becomes
motile after 3.5 h. Cell numbers counted from five randomly chosen fields
were averaged and rounded off to reflect the approximate assessment of
moving cells.
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FIGURE 5. Differential instability of axonemal complexes in each LC8 mutant.
Axonemal complexes were extracted by NaCl (A) or KI (B) buffer and
separated by velocity sedimentation through a 5–20% sucrose gradient. The
gradient fractions were analyzed by Western blots. A, differential dissociation
of ODA and I1. The ODA and I1 dynein from WT LC8 axonemes represented
by IC78 and IC140, respectively, sediment at ~20 S (arrowhead). LC8
primarily co-sediments with the ODA. In an LC8CT transformant (CC1331 as
well, not shown), I1 dissociates; both IC138 and IC140 sediment as distinct
smaller particles. In contrast, the ODA remain intact at ~20 S. Arrow
indicates the p28 peak for single-headed dyneins. In the LC8S90E gradient,
the ODA dissociates; both IC78 and IC69 sediment as distinct particles
(arrowheads in IC78 and IC69 panels), whereas I1 remains stable (arrowhead
in IC140 panel). LC8 largely co-sediments with IC69 of the ODA (arrowhead
in LC8 panel). The LC8S90A gradient is similar to that of WT. B, RS from
LC8CT axonemes dissociate upon extraction. Represented by RSP16, the RS
in fla14-LC8, fla14-LC8S90E, and fla14-LC8S90A extracts sediments as an
~20 S particle. In contrast, RSPs extracted from LC8CT strains sediment near
the top of the gradient indicating a drastic dissociation of the RS complex.
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FIGURE 6. Model explaining the influence of dimeric LC8 and LC8CT on
molecular complexes. Binding of the WT LC8 dimer (left) to the disordered
regions (squiggly lines) of target proteins (such as the dynein ICs) induces
refolding and thus promotes the association of additional subunits, e.g. IC97
in I1 dynein and the LC6 dimer in ODA. Mutant LC8 (LC8CT, right) binds to its
target proteins (the ICs), but the additional C-terminal tails at the interface
(triangles) interfere with the proper structural changes required for recruiting
IC97. Binding of the LC6 dimer is not affected by this mutation and thus no
impact on the ODA is observed. The inherent differences among scaffold
proteins and flanking molecules may determine the differential effects of LC8
modifications, including phosphorylation.
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